Eagle Pharmaceuticals names Richard A. Edlin to board
Mr. Edlin is a seasoned litigator with broad experience in both trial and appellate courts including the U.S. Supreme Court and the Delaware Supreme Court.
He has tried cases in federal and state courts all over the country and has handled domestic and international arbitrations.
At Greenberg Traurig, Mr. Edlin handles a wide variety of litigation and routinely acts for companies and their management in areas such as securities, general commercial and contractual disputes, antitrust and intellectual property.
Mr. Edlin is a member of the Board of Trustees of the Urban Justice Center; a member of the Board of Directors for Judges and Lawyers Breast Cancer Alert (JALBCA).
Mr. Edlin is a member of the Board of Governors of Hackensack University Medical Center, where he serves on the finance committee; and a trustee of The Carnegie Council for Ethics in International Affairs, where he serves as Treasurer and chairs the development and finance committees; a member of the Board of Governors, American Friends of Tel Aviv University.
He is a member of the Economic Club of New York; a fellow of the Litigation Council of America; and a trustee of New Jersey SEEDS, among other professional and community activities.
Mr. Edlin received his B.A. degree from Tufts University, magna cum laude in history and received his law degree from Columbia University School of Law, where he was a Harlan Fiske Stone Scholar and Notes editor of the Columbia Journal of Environmental Law.
Following his graduation, Mr. Edlin served as law clerk to Hon. Lee P. Gagliardi of the United States District Court for the Southern District of New York. ■
LATEST MOVES FROM New Jersey
- Wireless Telecom Group appoints Daniel Monopoli as CTO
- New Jersey Resources names Maureen Borkowski to board
- Milestone Scientific appoints Daniel Goldberger as CEO
- Celldex changes management team
- Pacira Pharmaceuticals appoints Mark I. Froimson to board
More inside POST